After Pfizer and Modern, the US is also giving clearance to Johnson's vaccine.

 

WASHINGTON DC : After Pfizer, Modern, Johnson & Johnson's coronavirus vaccine was also approved by a US consultant. The US administration official claimed that Johnson's vaccine was working well against corona. According to him, the vaccine developed by Johnson is getting good response even if it is applied to the critical corona patient. He claims that this vaccine is able to reduce the death rate in Corona.

Johnson & Johnson is pleased with the unprecedented response from the US Department of Health. The company has already been informed. By the end of March, they will be able to deliver 20 million doses of Corona Ticker. Already, more than 48 million people in the United States have received at least one dose of the corona tick. The Johnson & Johnson vaccine has been tested in Latin America and South Africa in addition to the United States. U.S. health consultants approved Johnson & Johnson's corona vaccine on Friday. They claim that this vaccine will show the country an alternative way to deal with the epidemic.

The Johnson & Johnson vaccine will be cleared for use in the country as a third vaccine on an emergency basis, the US Food and Drug Administration said in a statement. Accelerated corona vaccination across the country. Immunization programs are going on in different parts of the country.

 

U.S. administration officials say the vaccine needs to be cleared on an emergency basis before more Americans die in the Corona's new strain attack. Earlier, Johnson & Johnson claimed that a single vaccine made by them would make the human body resistant to coronavirus infection. The results of the third round of human body tests show that the vaccine has been shown to be "effective" in 72 percent of cases in the United States. However, in three continents of the world, the success rate of Johnson's tick test is more than 80 percent.

At the same time, Johnson & Johnson reported that their vaccines were 75 percent effective in preventing serious coronary heart disease. Even people with very low immunity or other physical problems may need to be vaccinated twice. Pfizer, the modern vaccination process is already underway in the United States. However, Corona's new strain is making the eyes red in that country as well. US administration officials are working to speed up the vaccination process. This time, America is going to give clearance to Johnson & Johnson's vaccine on an emergency basis.